TAC1 and migraine disorder: Similarly, Al-Hassany et al. highlighted that activation of the trigeminovascular system, particularly the release of CGRP, substance P, and neurokinin A, underpins migraine pathophysiology and contributes to peripheral and central sensitization processes that exacerbate migraine symptoms and reduce quality of life [42].